A Cochrane systematic review (April 2026) pooled 17 randomised trials with 20,342 participants.
-
A Cochrane systematic review (April 2026) pooled 17 randomised trials with 20,342 participants. It found anti-amyloid antibodies give little or no clinically meaningful benefit at 18 months in mild cognitive impairment or mild Alzheimer's dementia, plus about 107 more ARIA-E cases per 1,000. Only two trials tested approved drugs, which critics call a key limitation.
#medicine #alzheimer #dementia
https://psyll.com/articles/science/medicine-health/why-alzheimers-drugs-may-miss-the-clinical-mark
-
T #medicine shared this topic
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better đź’—
Register Login